Atlas Trials

TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors

Clinical trial NCT03778814 · RECRUITING

Trial details

NCT number
NCT03778814
Sponsor
Second Affiliated Hospital of Guangzhou Medical University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Nonsmall Cell Lung CancerSolid Tumor, Adult
Start date
2018-12-01
Primary completion
2029-12-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.